Cite
MLA Citation
David Hong et al.. “380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A231–A232. http://access.bl.uk/ark:/81055/vdc_100144719175.0x000005